(1S,3S)-3-acetyl-11-amino-1-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-3,6-dihydroxy-10-methoxy-2,4-dihydro-1H-tetracene-5,12-dione

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 蒽环类药物
• 英文名称: (1S,3S)-3-acetyl-11-amino-1-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-3,6-dihydroxy-10-methoxy-2,4-dihydro-1H-tetracene-5,12-dione
• 化学式: C₂₇H₃₀N₂O₉
• 分子量: 526.5
• InChiKey: IJKBFKGHBSORFS-QEEHIDTQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  38
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  192
• 氢给体数：
  5
• 氢受体数：
  11

文献信息

• ANTIANGIOGENIC SMALL MOLECULES AND METHODS OF USE
  申请人：The United States of America, as represented by the Secretary, Dept. of Health and Human Services

  公开号：US20160030508A1

  公开（公告）日：2016-02-04

  Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof.
• US9504729B2
  申请人：——

  公开号：US9504729B2

  公开（公告）日：2016-11-29
• [EN] ANTIANGIOGENIC SMALL MOLECULES AND METHODS OF USE<br/>[FR] PETITES MOLÉCULES ANTI-ANGIOGÉNIQUES ET PROCÉDÉS D'UTILISATION
  申请人：US HEALTH

  公开号：WO2011014825A2

  公开（公告）日：2011-02-03

  Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof.